Literature DB >> 21728018

Treatment of memory loss with herbal remedies.

Michael J Serby1, Sari J Burns, David M Roane.   

Abstract

OPINION STATEMENT: Increased rates of dementia throughout the world are creating an emergent need for successful preventive and treatment strategies. Despite a lack of any significant scientific basis, herbal remedies and other types of "complementary and alternative medicine" (CAM) are being aggressively marketed for both prophylactic and therapeutic effects in regard to memory disorders. In the past few years, a small number of controlled studies have explored the effectiveness of some of the more popular herbal and CAM remedies, including gingko biloba, phosphatidylcholine, phosphatidylserine, and omega-3 fatty acids. To date, the bulk of evidence suggests that such approaches are not successful in preventing or delaying cognitive decline or dementia, and there is little reason to prescribe these remedies for the treatment of established cognitive impairment. Some very preliminary evidence suggests that Gingko biloba may be useful in treating behavioral problems in demented people. It is likely that the absence of regulatory controls on the sale of herbal and CAM preparations will foster continued use of these agents and perhaps even accelerated use as the dementia epidemic increases, assuming no imminent breakthroughs in pharmacotherapy.

Entities:  

Year:  2011        PMID: 21728018     DOI: 10.1007/s11940-011-0135-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  12 in total

1.  A study of herbal remedies for memory complaints.

Authors:  Michael J Serby; Christine Yhap; Eva Y Landron
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

2.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

Authors:  Joseph F Quinn; Rema Raman; Ronald G Thomas; Karin Yurko-Mauro; Edward B Nelson; Christopher Van Dyck; James E Galvin; Jennifer Emond; Clifford R Jack; Michael Weiner; Lynne Shinto; Paul S Aisen
Journal:  JAMA       Date:  2010-11-03       Impact factor: 56.272

3.  Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.

Authors:  Ralf Ihl; Natalia Bachinskaya; Amos D Korczyn; Veronika Vakhapova; Michael Tribanek; Robert Hoerr; Oleksandr Napryeyenko
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-07       Impact factor: 3.485

4.  Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging.

Authors:  Rosebud O Roberts; James R Cerhan; Yonas E Geda; David S Knopman; Ruth H Cha; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Helen M O'Connor; Ronald C Petersen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease.

Authors:  J-H Heo; S-T Lee; K Chu; M J Oh; H-J Park; J-Y Shim; M Kim
Journal:  Eur J Neurol       Date:  2008-08       Impact factor: 6.089

6.  Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.

Authors:  Rob McCarney; Peter Fisher; Steve Iliffe; Robbert van Haselen; Mark Griffin; Jan van der Meulen; James Warner
Journal:  Int J Geriatr Psychiatry       Date:  2008-12       Impact factor: 3.485

7.  Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study.

Authors:  Ondine van de Rest; Avron Spiro; Elizabeth Krall-Kaye; Johanna M Geleijnse; Lisette C P G M de Groot; Katherine L Tucker
Journal:  J Nutr       Date:  2009-10-14       Impact factor: 4.798

8.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

9.  Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

Authors:  Beth E Snitz; Ellen S O'Meara; Michelle C Carlson; Alice M Arnold; Diane G Ives; Stephen R Rapp; Judith Saxton; Oscar L Lopez; Leslie O Dunn; Kaycee M Sink; Steven T DeKosky
Journal:  JAMA       Date:  2009-12-23       Impact factor: 56.272

10.  A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.

Authors:  H H Dodge; T Zitzelberger; B S Oken; D Howieson; J Kaye
Journal:  Neurology       Date:  2008-02-27       Impact factor: 9.910

View more
  3 in total

1.  Assessing and treating forgetfulness and cognitive problems in adults with HIV.

Authors:  David E Vance; Pariya L Fazeli; Linda Moneyham; Norman L Keltner; James L Raper
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

2.  Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research.

Authors:  David E Vance
Journal:  ISRN Nurs       Date:  2013-02-03

3.  Gain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome.

Authors:  Sérgio B Sousa; Dagan Jenkins; Estelle Chanudet; Guergana Tasseva; Miho Ishida; Glenn Anderson; James Docker; Mina Ryten; Joaquim Sa; Jorge M Saraiva; Angela Barnicoat; Richard Scott; Alistair Calder; Duangrurdee Wattanasirichaigoon; Krystyna Chrzanowska; Martina Simandlová; Lionel Van Maldergem; Philip Stanier; Philip L Beales; Jean E Vance; Gudrun E Moore
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.